< 1 minute read
Nov. 3, 2021
An Oral BMS HPK1 Inhibitor Tool Compound from Homology Modeling
BMS compound 24 - HPK1
50x family-selective HPK1 kinase inhibitor tumor clearance w/ PD-1i (oral 100 mpk BID) from IRAK4 inhibitor and homology modeling ACS. Med. Chem. Lett., Feb. 19, 2021 Bristol Myers Squibb, Cambridge, MA
Loading...
